Tianci Du

Lanzhou University Second Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Tianci Du is a urological surgeon whose research focuses on advancing minimally invasive treatments for ureteropelvic junction obstruction (UPJO). His most notable contribution is a comprehensive systematic review and meta-analysis comparing secondary versus primary minimally invasive pyeloplasty (MIP) for UPJO management. This work critically evaluates whether repeat MIP offers comparable outcomes to initial procedures, providing essential guidance for surgeons treating recurrent obstructions. By synthesizing data from major databases including PubMed, Web of Science, EMBASE, and the Cochrane Library, Du’s research helps clarify optimal surgical strategies for complex cases. His meta-analysis, published in 2022, has garnered 2 citations, establishing a foundation for evidence-based decision-making in reconstructive urology. Du’s work addresses a significant clinical gap—the safety and efficacy of secondary MIP—and contributes to the broader movement toward less invasive urological interventions. His systematic approach to evaluating surgical outcomes demonstrates a commitment to rigorous methodology and patient-centered care. For researchers and clinicians specializing in UPJO, Du’s findings offer valuable insights into managing this challenging condition, particularly when primary interventions fail.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Secondary and Primary Minimally Invasive Pyeloplasty in the Treatment of Ureteropelvic Junction Obstruction: A Systematic Review and Meta-Analysis
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Lanzhou University Second Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago